US OptionsDetailed Quotes
GLUE241220C2500
- 6.20
- 0.000.00%
15min DelayClose Nov 25 16:00 ET
0.00High0.00Low
6.20Open6.20Pre Close0 Volume1 Open Interest2.50Strike Price0.00Turnover0.00%IV2.84%PremiumDec 20, 2024Expiry Date5.96Intrinsic Value100Multiplier24DDays to Expiry0.24Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma1.54Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Monte Rosa Therapeutics Stock Discussion
Monte Rosa Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Versant Venture Capital VI, L.P.(6.6%),Versant Ventures VI GP, L.P.(6.6%), etc.
Monte Rosa Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Versant Venture Capital VI, L.P.
No comment yet